M
$ Value
$11K
Shares
4,609
Price
$2
Filed
Oct 8
Insider
Name
Raykov Rosty
Title
—
CIK
0001468316
Roles
Director
Transaction Details
Transaction Date
2025-10-08
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,634,184
Footnotes
Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026.
Filing Info
Raykov Rosty's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | FENC | M | $38K |
| 2026-04-01 | FENC | ▼ | $69K |
| 2026-04-01 | FENC | M | $38K |
| 2026-03-31 | FENC | A | $0 |
| 2026-03-02 | FENC | M | $38K |
| 2026-03-02 | FENC | ▼ | $84K |
| 2026-03-02 | FENC | M | $38K |
| 2026-02-28 | FENC | A | $0 |
| 2026-02-02 | FENC | M | $38K |
| 2026-02-02 | FENC | ▼ | $80K |
Other Insiders at FENC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Andrade Robert
CHIEF FINANCIAL OFFICER
|
— | — | 2026-03-31 |
| Raykov Rosty | — | $234K | 2026-04-01 |
|
Hackman Jeffrey S.
Chief Executive Officer
|
— | — | 2026-03-31 |
|
Evans Terry L
Chief Commercial Officer
|
— | — | 2026-03-31 |
|
Sayad Pierre Sargis
Chief Medical Officer
|
— | — | 2026-03-31 |
|
Cioffi Christiana Marie
Chief Strategy Officer
|
— | — | 2026-03-31 |